DD147242A5 - Verfahren zur herstellung von pyrido eckige klammer auf 2,1-b eckige klammer zu-chinazolinon-derivaten - Google Patents

Verfahren zur herstellung von pyrido eckige klammer auf 2,1-b eckige klammer zu-chinazolinon-derivaten Download PDF

Info

Publication number
DD147242A5
DD147242A5 DD79216232A DD21623279A DD147242A5 DD 147242 A5 DD147242 A5 DD 147242A5 DD 79216232 A DD79216232 A DD 79216232A DD 21623279 A DD21623279 A DD 21623279A DD 147242 A5 DD147242 A5 DD 147242A5
Authority
DD
German Democratic Republic
Prior art keywords
pyrido
general formula
groups
group
propionic acid
Prior art date
Application number
DD79216232A
Other languages
German (de)
English (en)
Inventor
Helmut Biere
Joachim-Friedrich Kapp
Irmgard Boettcher
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DD147242A5 publication Critical patent/DD147242A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Organic Insulating Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DD79216232A 1978-10-18 1979-10-15 Verfahren zur herstellung von pyrido eckige klammer auf 2,1-b eckige klammer zu-chinazolinon-derivaten DD147242A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782845766 DE2845766A1 (de) 1978-10-18 1978-10-18 Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
DD147242A5 true DD147242A5 (de) 1981-03-25

Family

ID=6052696

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79216232A DD147242A5 (de) 1978-10-18 1979-10-15 Verfahren zur herstellung von pyrido eckige klammer auf 2,1-b eckige klammer zu-chinazolinon-derivaten

Country Status (25)

Country Link
US (1) US4457927A (fr)
EP (1) EP0011142B1 (fr)
JP (1) JPS5557588A (fr)
AT (1) ATE2146T1 (fr)
AU (1) AU529643B2 (fr)
CA (1) CA1130805A (fr)
CS (1) CS216512B2 (fr)
DD (1) DD147242A5 (fr)
DE (2) DE2845766A1 (fr)
DK (1) DK154297C (fr)
EG (1) EG14028A (fr)
ES (1) ES8103745A1 (fr)
FI (1) FI793229A (fr)
FR (1) FR2439199A1 (fr)
GB (1) GB2034705B (fr)
GR (1) GR73819B (fr)
IE (1) IE48852B1 (fr)
IL (1) IL58474A0 (fr)
NO (1) NO793344L (fr)
NZ (1) NZ191828A (fr)
PL (3) PL123075B1 (fr)
PT (1) PT70329A (fr)
RO (1) RO78339A (fr)
SU (1) SU1001857A3 (fr)
ZA (1) ZA795559B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3300477A1 (de) * 1983-01-08 1984-07-12 Boehringer Ingelheim KG, 6507 Ingelheim Neue heterocyclische verbindungen, ihre herstellung und verwendung
US4587339A (en) * 1983-10-14 1986-05-06 Sun Chemical Corporation Nickel complex pigments of bis-azomethines
CZ281628B6 (cs) * 1991-07-29 1996-11-13 Warner-Lambert Company Deriváty chinazolinu a farmaceutické přípravky na jejich bázi
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
CA2238283C (fr) 1997-05-30 2002-08-20 Cell Pathways, Inc. Methode d'identification de composes visant a inhiber les lesions neoplasiques, compositions pharmaceutiques a prtir de ces composes et compositions pour traiter les lesions neoplasiques
US6410584B1 (en) * 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6025394A (en) 1999-01-29 2000-02-15 Cell Pathways, Inc. Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia
US6555547B1 (en) 2000-02-28 2003-04-29 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
US6569638B1 (en) 2000-03-03 2003-05-27 Cell Pathways, Inc Method for screening compounds for the treatment of neoplasia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1064259A (en) * 1963-12-19 1967-04-05 Union Pharma Scient Appl New derivatives of 2-anilino-nicotinic acid and process for their preparation
US4033961A (en) * 1975-10-07 1977-07-05 Warner-Lambert Company Pyrido[2-1-b]quinazolin-ones and their methods of preparation
DE2557425C2 (de) * 1975-12-19 1987-03-19 C.H. Boehringer Sohn, 6507 Ingelheim 11-Oxo-11-H-pyrido[2,1-b]-chinazolin-2-carbonsäure und ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel
US4066767A (en) * 1976-11-01 1978-01-03 Warner-Lambert Company 8-(1H-Tetrazol-5-yl)-11H-pyrido[2,1-b]quinazolin-11-ones and method of treating bronchial asthma using them
PH13915A (en) * 1977-03-24 1980-11-04 Hoffmann La Roche Chinazoline derivatives

Also Published As

Publication number Publication date
ZA795559B (en) 1980-09-24
ES485162A0 (es) 1981-03-16
IL58474A0 (en) 1980-01-31
CS216512B2 (en) 1982-11-26
PL119174B1 (en) 1981-12-31
FR2439199A1 (fr) 1980-05-16
PT70329A (de) 1979-11-01
AU5183279A (en) 1980-04-24
NO793344L (no) 1980-04-21
IE791969L (en) 1980-04-18
ATE2146T1 (de) 1983-01-15
GR73819B (fr) 1984-05-03
GB2034705B (en) 1982-12-08
RO78339A (fr) 1982-04-12
JPS5557588A (en) 1980-04-28
DK154297C (da) 1989-03-28
ES8103745A1 (es) 1981-03-16
PL123430B1 (en) 1982-10-30
IE48852B1 (en) 1985-05-29
PL218993A1 (fr) 1980-06-16
GB2034705A (en) 1980-06-11
NZ191828A (en) 1983-03-15
FI793229A (fi) 1980-04-19
EG14028A (en) 1982-09-30
EP0011142A1 (fr) 1980-05-28
AU529643B2 (en) 1983-06-16
DK154297B (da) 1988-10-31
EP0011142B1 (fr) 1982-12-29
CA1130805A (fr) 1982-08-31
DE2964431D1 (en) 1983-02-03
SU1001857A3 (ru) 1983-02-28
DE2845766A1 (de) 1980-04-30
DK438379A (da) 1980-04-19
PL123075B1 (en) 1982-09-30
JPS634537B2 (fr) 1988-01-29
US4457927A (en) 1984-07-03

Similar Documents

Publication Publication Date Title
DD147242A5 (de) Verfahren zur herstellung von pyrido eckige klammer auf 2,1-b eckige klammer zu-chinazolinon-derivaten
DE2614406C2 (fr)
DE69723447T2 (de) Substituierte indazolderivate und ihre verwendung als inhibitoren des phosphodiesterase (pde) typs 4 und des tumor-necrosin-factors (tnf)
DE69021501T2 (de) Anti-entzündende 4-aminophenol-derivate.
DE60215699T2 (de) Quinolinone als prostaglandin rezeptor liganden
EP1017692A1 (fr) 4-heteroaryle-tetrahydroquinoleines et leur utilisation comme inhibiteurs de la proteine de transfert cholesterine-ester
DE60006054T2 (de) Herstellungsverfahren für Pyridinderivate
DD267047A5 (de) Verfahren zur herstellung von pyrrolobenzimidazolen
DE10046029A1 (de) Indazole
DE3916663A1 (de) Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
CH639662A5 (de) Imidazoazine und imidazodiazine.
DD280323A5 (de) Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten
DE3907388A1 (de) Verfahren zur herstellung von indolcarbonsaeurederivaten
DE2449030A1 (de) Neue pyridin-derivate
DE2508543A1 (de) Verfahren zur herstellung von imidazo- und pyrimido eckige klammer auf 2,1-b eckige klammer zu -chinazolinen und neue chinazoline
CH642650A5 (de) Verfahren zur herstellung neuer benzopyranderivate.
DE2536003A1 (de) Neue pyrazol-derivate, ihre herstellung und verwendung
EP0225522A1 (fr) Imidazopyridazine-alkènecarboxamides, leur procédé de préparation, produits intermédiaires et leur préparation
WO1994012498A1 (fr) NOUVEAU PROCEDE DE PREPARATION DE β-CARBOLINES
EP0094038B1 (fr) 3-Amino-6-aryl-1,2,4-triazolo(4,3-b)pyridazines, leur préparation et leur utilisation
DE3781703T2 (de) 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel.
US6303787B1 (en) Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
EP0253171A1 (fr) Pyrido[1,8]naphtyridinones, leur procédé de préparation, leur utilisation et compositions les contenant
DE1908496A1 (de) Neue Thiophenderivate und Verfahren zu ihrer Herstellung
DE2739020A1 (de) Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung